home Apparatus

Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy!

  • Nov 19, 2024

New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer!

  • Nov 18, 2024

FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit!

  • Nov 17, 2024

Ovarian Cancer Heavyweight Cutting-Edge ADC Drug Elahere Proven Safe And Effective

  • Nov 16, 2024

Heavyweight! First ADC Drug Approved For Hormone Receptor-Positive Breast Cancer!

  • Nov 15, 2024

The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma!

  • Nov 14, 2024

The New Generation Of Breast Cancer SERD Drug, Elastoxan, Shows Promise!

  • Nov 13, 2024

New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity

  • Nov 12, 2024

World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy!

  • Nov 11, 2024

New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely!

  • Nov 10, 2024